• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚胺培南对从临床标本中分离出的重要需氧菌和厌氧菌的体外抗菌作用。

Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.

作者信息

Klietmann W, Focht J, Nösner K

机构信息

Institut für Labormedizin, Fed. Rep. of Germany.

出版信息

Chemioterapia. 1987 Aug;6(4):243-50.

PMID:3477332
Abstract

Imipenem is a thienamycin antibiotic of the first generation with broad antibacterial activity. It covers all gram-positive organisms (including Streptococcus faecalis) and gram-negative bacteria (including Pseudomonas aeruginosa and Serratia spp.) as well as Bacteroides fragilis and other Bacteroides species. In this comparative study the antimicrobic effect against 1020 gram-negative, 927 gram-positive and 352 anaerobic strains from fresh clinical isolates was tested and compared with that of other frequently used antibiotics. The minimum inhibitory concentrations (MIC) were determined by means of a serial dilution test with micro standard plates. Within the group of gram-negative strains, imipenem was the most active antibiotic with a MIC90 of less than or equal to 0.25 mg/l for most isolates. Imipenem shows a broad spectrum of activity against gram-negative pathogenic bacteria including Escherichia coli, Klebsiella spp., Proteus spp, Enterobacter spp., Citrobacter spp. and Serratia spp., and also covers resistant strains of Pseudomonas aeruginosa, Acinetobacter spp. and Alcaligenes faecalis. Imipenem also shows high inhibiting activity against gram-positive strains and anaerobic pathogens.

摘要

亚胺培南是第一代硫霉素类抗生素,具有广泛的抗菌活性。它涵盖所有革兰氏阳性菌(包括粪肠球菌)、革兰氏阴性菌(包括铜绿假单胞菌和沙雷氏菌属)以及脆弱拟杆菌和其他拟杆菌属。在这项比较研究中,测试了亚胺培南对来自新鲜临床分离株的1020株革兰氏阴性菌、927株革兰氏阳性菌和352株厌氧菌的抗菌效果,并与其他常用抗生素进行了比较。最低抑菌浓度(MIC)通过微量标准平板系列稀释试验测定。在革兰氏阴性菌组中,亚胺培南是活性最强的抗生素,大多数分离株的MIC90小于或等于0.25mg/L。亚胺培南对包括大肠杆菌、克雷伯菌属、变形杆菌属、肠杆菌属、柠檬酸杆菌属和沙雷氏菌属在内的革兰氏阴性病原菌具有广谱活性,还涵盖铜绿假单胞菌、不动杆菌属和粪产碱杆菌的耐药菌株。亚胺培南对革兰氏阳性菌和厌氧病原菌也显示出高抑制活性。

相似文献

1
Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.亚胺培南对从临床标本中分离出的重要需氧菌和厌氧菌的体外抗菌作用。
Chemioterapia. 1987 Aug;6(4):243-50.
2
Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.环丙沙星对临床分离的需氧菌和厌氧菌的体外活性比较
Arzneimittelforschung. 1987 Jun;37(6):661-6.
3
Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.亚胺培南对临床分离的革兰氏阳性和革兰氏阴性需氧菌的体外比较活性。
Microbiologica. 1988 Apr;11(2):137-42.
4
In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.新型碳青霉烯类抗生素美罗培南的体外及体内抗菌活性
Drugs Exp Clin Res. 1992;18(2):37-46.
5
CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.CEM-101,一种新型氟酮内酯:对多种革兰氏阳性菌和革兰氏阴性菌的抗菌活性。
Diagn Microbiol Infect Dis. 2010 Apr;66(4):393-401. doi: 10.1016/j.diagmicrobio.2009.10.013.
6
In vitro activity of ertapenem: review of recent studies.厄他培南的体外活性:近期研究综述
J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii11-21. doi: 10.1093/jac/dkh204.
7
Antimicrobial activity of imipenem against 1386 clinical isolates.亚胺培南对1386株临床分离菌的抗菌活性。
Methods Find Exp Clin Pharmacol. 1986 Nov;8(11):675-8.
8
In vitro activity of imipenem against gram-positive anaerobic bacteria.亚胺培南对革兰氏阳性厌氧菌的体外活性。
Int J Clin Pharmacol Res. 1987;7(1):39-43.
9
In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.新型广谱β-内酰胺类抗生素对肠杆菌科细菌和非发酵菌的体外活性:来自奥地利重症监护病房的报告。奥地利碳青霉烯敏感性监测组
Wien Klin Wochenschr. 1999 Jul 30;111(14):549-54.
10
Comparative in vitro activity of imipenem and 15 other antimicrobial agents against clinically important aerobic and anaerobic bacteria.
Clin Ther. 1988;10(5):487-515.